DE69813681D1 - Neue triazole als therapeutische mittel gegen pilzinfektionen - Google Patents
Neue triazole als therapeutische mittel gegen pilzinfektionenInfo
- Publication number
- DE69813681D1 DE69813681D1 DE69813681T DE69813681T DE69813681D1 DE 69813681 D1 DE69813681 D1 DE 69813681D1 DE 69813681 T DE69813681 T DE 69813681T DE 69813681 T DE69813681 T DE 69813681T DE 69813681 D1 DE69813681 D1 DE 69813681D1
- Authority
- DE
- Germany
- Prior art keywords
- therapeutic agent
- agent against
- new triazole
- against mushroom
- infection
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
- C07D241/04—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
- C07D249/10—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
- C07D249/10—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D249/12—Oxygen or sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
- C07D249/10—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D249/14—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
- C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D257/04—Five-membered rings
- C07D257/06—Five-membered rings with nitrogen atoms directly attached to the ring carbon atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/38—Nitrogen atoms
- C07D277/42—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US78637697A | 1997-01-17 | 1997-01-17 | |
PCT/IB1998/000046 WO1998031675A1 (en) | 1997-01-17 | 1998-01-15 | New triazoles as therapeutic agents for fungal infections |
Publications (1)
Publication Number | Publication Date |
---|---|
DE69813681D1 true DE69813681D1 (de) | 2003-05-28 |
Family
ID=25138405
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69813681T Expired - Lifetime DE69813681D1 (de) | 1997-01-17 | 1998-01-15 | Neue triazole als therapeutische mittel gegen pilzinfektionen |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP0889881B1 (de) |
JP (1) | JP2000507275A (de) |
KR (1) | KR20000064644A (de) |
AT (1) | ATE238286T1 (de) |
AU (1) | AU740324B2 (de) |
CA (1) | CA2249529A1 (de) |
DE (1) | DE69813681D1 (de) |
WO (1) | WO1998031675A1 (de) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19617040C1 (de) * | 1996-04-27 | 1997-10-30 | Degussa | Verfahren zur Herstellung katalytisch wirksamer Beschichtungen für die Synthese von Cyanwasserstoff |
CN1137102C (zh) * | 2000-05-24 | 2004-02-04 | 中国人民解放军第二军医大学 | 取代丙基三唑类抗真菌化合物和其盐类以及制备方法 |
EP1330444B1 (de) | 2000-11-01 | 2011-03-23 | Millennium Pharmaceuticals, Inc. | Stickstoffhaltige heterozyklische verbindungen und verfahren zu deren herstellung |
HUP0303249A3 (en) | 2001-02-22 | 2007-03-28 | Sankyo Co | Water-soluble triazole fungicide compounds and pharmaceutical compositions containing them |
KR100909953B1 (ko) * | 2007-06-15 | 2009-07-31 | 한국화학연구원 | 항진균 활성을 갖는 트라이아졸 유도체, 이의 제조방법 및이를 함유하는 약학 조성물 |
KR101577053B1 (ko) | 2013-11-20 | 2015-12-11 | 한국화학연구원 | 트리아졸 유도체를 포함하는 탈모 예방 및 발모 촉진용 조성물과 탈모 예방 및 발모 촉진용 화장료 조성물 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3508909A1 (de) * | 1985-03-13 | 1986-09-18 | Bayer Ag, 5090 Leverkusen | Piperazinylmethyl-1,2,4-triazolylmethyl-carbinole |
GB8729083D0 (en) * | 1987-12-12 | 1988-01-27 | Pfizer Ltd | Triazole antifungal agents |
-
1998
- 1998-01-15 JP JP10534037A patent/JP2000507275A/ja active Pending
- 1998-01-15 AU AU53362/98A patent/AU740324B2/en not_active Ceased
- 1998-01-15 EP EP98900110A patent/EP0889881B1/de not_active Expired - Lifetime
- 1998-01-15 DE DE69813681T patent/DE69813681D1/de not_active Expired - Lifetime
- 1998-01-15 AT AT98900110T patent/ATE238286T1/de not_active IP Right Cessation
- 1998-01-15 KR KR1019980707355A patent/KR20000064644A/ko not_active Application Discontinuation
- 1998-01-15 WO PCT/IB1998/000046 patent/WO1998031675A1/en not_active Application Discontinuation
- 1998-01-15 CA CA002249529A patent/CA2249529A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
EP0889881B1 (de) | 2003-04-23 |
KR20000064644A (ko) | 2000-11-06 |
CA2249529A1 (en) | 1998-07-23 |
ATE238286T1 (de) | 2003-05-15 |
EP0889881A1 (de) | 1999-01-13 |
WO1998031675A1 (en) | 1998-07-23 |
AU740324B2 (en) | 2001-11-01 |
AU5336298A (en) | 1998-08-07 |
JP2000507275A (ja) | 2000-06-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE60030741D1 (de) | Chinazoline verbindungen als heilmittel | |
BR0212042A (pt) | Composto, composição farmacêutica, método de tratamento ou prevenção de doenças, e, uso de um composto | |
LU91928I2 (fr) | Ipilimumab et ses dérivés pharmaceutiquement acceptables (YERVOY®) | |
AU2002236765A1 (en) | Pharmaceutical combination for the treatment of cancer containing a 4-quinazolineamine and another anti-neoplastic agent | |
TR200200579T2 (tr) | Amino-tirazolpiridin türevleri. | |
SE9604786D0 (sv) | New compounds | |
NO20034204D0 (no) | Farmasöytiske kombinasjoner til behandling av kreft | |
UA49869C2 (uk) | Нафтил-заміщені похідні бензимідазолу, фармацевтична композиція, спосіб лікування (варіанти) та спосіб інгібування людського фактора | |
SE9504661D0 (sv) | New compounds | |
DK0950057T3 (da) | 3-pyridylenantiomerer og deres anvendelse som analgetika | |
MY119375A (en) | Treatment of tinnitus using neuroprotective agents | |
ATE260658T1 (de) | Pharmazeutische zubereitungen zur verminderung von atmungsdepressionen | |
NO953370L (no) | Anvendelse av riluzol ved behandling av neuro-AIDS | |
GB0130677D0 (en) | Medicaments and novel compounds | |
PT736029E (pt) | Sulfamatos de pseudofructopiranose anticonvulsivos | |
FI934680A0 (fi) | Arylmorfolin, framstaellning och anvaending | |
GEP20043227B (en) | 5HT1 Antagonists for Antidepressant Therapy | |
DE69813681D1 (de) | Neue triazole als therapeutische mittel gegen pilzinfektionen | |
GB9907571D0 (en) | Compounds | |
CA2289017A1 (en) | The use of a nitroxide or a prodrug thereof in the prophylactic and therapeutic treatment of cancer | |
ATE250610T1 (de) | Kaliumkanal-blockierende mittel | |
DE69711779D1 (de) | Neue Melatonin-Derivaten als Wirkstoff gegen freien Radikale sowie diese enthaltende Präparate | |
DE69635806D1 (de) | Diphosphonat derivate von therapeutisch wirksamen stoffen | |
NZ504614A (en) | Echinocandin derivatives and application as anti-fungal agents | |
SE9704770D0 (sv) | New use |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8332 | No legal effect for de |